BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28718037)

  • 1. Cost-Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma.
    Royce TJ; Punglia RS; Chen AB; Patel SA; Thornton KA; Raut CP; Baldini EH
    Ann Surg Oncol; 2017 Oct; 24(11):3264-3270. PubMed ID: 28718037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
    Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA.
    Wu CF; Lin L; Mao YP; Deng B; Lv JW; Zheng WH; Wen DW; Kou J; Chen FP; Yang XL; Xu SS; Ma J; Zhou GQ; Sun Y
    BMC Med; 2021 Aug; 19(1):193. PubMed ID: 34433440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas.
    Fleming JB; Cantor SB; Varma DG; Holst D; Feig BW; Hunt KK; Patel SR; Benjamin RS; Pollock RE; Pisters PW
    Cancer; 2001 Aug; 92(4):863-8. PubMed ID: 11550159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.
    Patel SA; Royce TJ; Barysauskas CM; Thornton KA; Raut CP; Baldini EH
    Ann Surg Oncol; 2017 Jun; 24(6):1588-1595. PubMed ID: 28058559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.
    Auguste P; Barton P; Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Khan K; Sundar S; Roberts T
    BJOG; 2014 Mar; 121(4):464-76. PubMed ID: 24299112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective.
    Bae S; Karnon J; Crane G; Bessen T; Desai J; Crowe P; Neuhaus S
    Cost Eff Resour Alloc; 2020; 18():5. PubMed ID: 32042270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma.
    Goel A; Christy ME; Virgo KS; Kraybill WG; Johnson FE
    Int J Oncol; 2004 Aug; 25(2):429-35. PubMed ID: 15254741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
    Huntington SF; Svoboda J; Doshi JA
    J Clin Oncol; 2015 May; 33(13):1467-74. PubMed ID: 25823735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?
    Gamboa AC; Ethun CG; Switchenko JM; Lipscomb J; Poultsides GA; Grignol V; Howard JH; Gamblin TC; Roggin KK; Votanopoulos K; Fields RC; Maithel SK; Delman KA; Cardona K
    J Am Coll Surg; 2019 Nov; 229(5):449-457. PubMed ID: 31377411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective follow-up strategies in soft tissue sarcoma.
    Whooley BP; Mooney MM; Gibbs JF; Kraybill WG
    Semin Surg Oncol; 1999; 17(1):83-7. PubMed ID: 10402642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.
    Porter GA; Cantor SB; Ahmad SA; Lenert JT; Ballo MT; Hunt KK; Feig BW; Patel SR; Benjamin RS; Pollock RE; Pisters PW
    Cancer; 2002 Jan; 94(1):197-204. PubMed ID: 11815977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
    Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
    Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?
    Phippen NT; Havrilesky LJ; Barnett JC; Hamilton CA; Stany MP; Lowery WJ
    Int J Gynecol Cancer; 2016 Jun; 26(5):944-50. PubMed ID: 27051057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer.
    Wu JX; Beni CE; Zanocco KA; Sturgeon C; Yeh MW
    Thyroid; 2015 Jul; 25(7):797-803. PubMed ID: 25851702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Preoperative Versus Postoperative Radiation Therapy in Extremity Soft Tissue Sarcoma.
    Qu XM; Louie AV; Ashman J; Wasif N
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):339-346. PubMed ID: 28068242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Surveillance After Extremity Tumor Surgery (SAFETY) trial: protocol for a pilot study to determine the feasibility of a multi-centre randomised controlled trial.
    SAFETY Investigators
    BMJ Open; 2019 Sep; 9(9):e029054. PubMed ID: 31537562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
    Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.